Hedge Fund - Acuta Capital Partners
Cymabay Therapeutics Inc. (CBAY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $11,624,701 | 6.54% | 492,155 | $17.81 |
| 2 | 2023 - Q3 (2023-09-30) | $6,232,380 | 4.17% | 418,000 | $13.26 |
| 3 | 2023 - Q2 (2023-06-30) | $4,708,500 | 3.18% | 430,000 | $9.31 |
| 4 | 2023 - Q1 (2023-03-31) | $7,660,520 | 5.64% | 878,500 | $8.01 |
| 5 | 2022 - Q4 (2022-12-31) | $6,364,050 | 3.91% | 1,015,000 | $3.80 |
| 6 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $3.80 |
| 7 | 2021 - Q3 (2021-09-30) | $1,102,000 | 0.38% | 301,904 | $3.94 |
| 8 | 2021 - Q2 (2021-06-30) | $1,316,000 | 0.52% | 301,904 | $4.43 |
| 9 | 2021 - Q1 (2021-03-31) | $1,432,000 | 0.51% | 315,341 | $5.38 |
| 10 | 2020 - Q4 (2020-12-31) | $1,894,000 | 0.51% | 330,000 | $7.57 |
| 11 | 2020 - Q3 (2020-09-30) | $5,539,000 | 1.5% | 765,000 | $5.35 |
| 12 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $11.32 |
| 13 | 2019 - Q1 (2019-03-31) | $6,872,000 | 3.26% | 517,500 | $10.64 |
The displayed share prices are average quarterly stock market prices.